- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 245/02 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
Patent holdings for IPC class C07D 245/02
Total number of patents in this class: 59
10-year publication summary
5
|
2
|
2
|
5
|
4
|
1
|
1
|
3
|
2
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19989 |
7 |
Translate bio, Inc. | 417 |
4 |
F. Hoffmann-La Roche AG | 7945 |
2 |
Massachusetts Institute of Technology | 10066 |
2 |
Purdue Research Foundation | 3638 |
2 |
Irresistible Materials Ltd | 11 |
2 |
Teijin Limited | 1248 |
2 |
TONIX Pharmaceuticals Holding Corp | 34 |
2 |
Tonix Pharmaceuticals, Inc. | 42 |
2 |
The Trustees of Boston College | 195 |
2 |
Chengdu Kaoensi Science and Technology Co., Ltd. | 2 |
2 |
Novartis AG | 10741 |
1 |
Bristol-myers Squibb Company | 4881 |
1 |
Genentech, Inc. | 3978 |
1 |
Evonik Industries AG | 224 |
1 |
Uop LLC | 4240 |
1 |
The Board of Trustees of the University of Illinois | 2702 |
1 |
University of Florida Research Foundation, Inc. | 4037 |
1 |
Alkahest, Inc. | 95 |
1 |
Ariel-the University Company for Research and Development, Ltd. | 1 |
1 |
Other owners | 21 |